Search - tctmd.com

Displaying 1 - 20 of 78

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

Remission From Prediabetes Halves CV Risk: Registry Data

Yael L. Maxwell

December 19, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Caitlin E. Cox

November 18, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Todd Neale

April 28, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

Todd Neale

August 01, 2024

News Daily News

No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data

Yael L. Maxwell

July 15, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

Advertisement

December 2025 Dispatch for the CV Team

Remission From Prediabetes Halves CV Risk: Registry Data

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

GLP-1 Drugs May Have Role in Secondary Prevention of AF

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Semaglutide May Ease Tobacco Use, Study Suggests

No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content